Patent ID: 8273733

Claim:
A method for treating a pathology selected from the group consisting of obesity and diabetes, said method comprising administering to a patient in need thereof an effective amount of compound of formula I: wherein: n represents a value from 1 to 6; —(C)n- represents a C 1-6 alkylidene group optionally substituted with 1 to 4 substituents selected from halogen, hydroxyl, nitro, cyano, amino, C 1-3 monoalkylamino, C 2-6 dialkylamino and C 1-3 alkoxy; R1 represents a hydrogen atom or a C 1-6 alkyl group; R2 represents a hydrogen atom, or a C 1-6 alkyl or C 3-6 cycloalkyl group optionally substituted with 1 to 4 substituents selected from a halogen atom, a hydroxyl, nitro, cyano, amino, C 1-3 monoalkylamino, C 2-6 dialkylamino, C 1-2 perhaloalkyl, C 1-3 haloalkyl, C 1-3 alkoxy, C 3-6 cycloalkyl, a monocyclic heteroaryl, and an aryl; the aryl being optionally substituted with 1 to 4 substituents selected from a halogen atom, a hydroxyl, nitro, cyano, amino, C 1-3 monoalkylamino, C 2-6 dialkylamino, C 1-3 alkyl, C 1-2 perhaloalkyl, C 1-3 haloalkyl, C 1-3 alkoxy and a C 1-3 alkylidenedioxy group; B represents NR3R4, wherein R3 and R4 represent, independently of one another, a C 1-6 alkyl group, or a hydrogen atom; or R3 and R4 together represent a C 1-6 alkylidene group, a C 2-8 alkenylidene group, a C 1-3 alkylidene-O—C 1-3 alkylidene group, or a C 1-3 alkylidene-N(R5)-C 1-3 alkylidene group where R5 represents a hydrogen atom, or a C 1-3 alkyl or C 1-6 alkylcarbonyl group, it being possible for these C 1-3 alkyl and C 1-6 alkylcarbonyl groups to be substituted with a halogen atom, or a hydroxyl, C 1-3 alkoxy, nitro, cyano or amino group; or B represents an aminocycle, linked via a carbon to the group —NR1-(C)n-, said aminocycle being selected from aziridine, azetidine, pyrrolidine, piperidine and morpholine; the groups R3 and R4 and also the aminocycle being optionally substituted with 1 to 4 substituents selected from a phenyl, a benzyl, a halogen, a hydroxyl, a nitro, cyano, amino, C 1-3 monoalkylamino, C 2-6 dialkylamino, C 1-3 alkyl and C 1-3 alkoxy group; the nitrogen atom being optionally substituted with a C 1-3 alkyl; or a salt, a hydrate or a solvate thereof; with the exclusion of the compound in which R 1 and R 2 represent hydrogen atoms, B represents a dimethylamino group and —(C)n- represents an ethylidene group.